Literature DB >> 12027077

Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis.

Bernard Yu-Hor Thong1, Khai-Pang Leong, Hiok-Hee Chng.   

Abstract

BACKGROUND: Dapsone 100 mg/pyrimethamine 12.5 mg (Maloprim; Beacons Chemicals Pte Ltd, Singapore) is routinely prescribed for antimalarial chemoprophylaxis in military servicemen in Singapore who are not glucose-6-phosphate dehydrogenase-deficient.
METHODS: We report a series of three male National Servicemen with hypersensitivity syndrome from Maloprim.
RESULTS: The three patients were diagnosed with hypersensitivity syndrome based on the presence of features of a drug hypersensitivity syndrome including fever, lymphadenopathy, maculopapular exanthema, hepatitis, and definite exposure to weekly Maloprim alone. A mild Coombs positive hemolytic anemia was also observed in one patient. All the clinical, hematologic, and biochemical derangements normalized within 3 months of tapering regimens of moderate-dose prednisolone.
CONCLUSIONS: Drug hypersensitivity syndromes can occur even on low-dose, weekly drug regimens. Hypersensitivity syndrome from weekly Maloprim is potentially reversible when recognized and treated early.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027077     DOI: 10.1016/S1081-1206(10)62394-0

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  1 in total

1.  Effects of pyrimethamine versus proguanil in malarial chemoprophylaxis in children with sickle cell disease: a randomized, placebo-controlled, open-label study.

Authors:  Felicia U Eke; Ifeoma Anochie
Journal:  Curr Ther Res Clin Exp       Date:  2003-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.